| Otic formulations for drug-induced ototoxicity |
2022-5-01 |
2022-7-01 |
|
| Triglyceride otic formulations and uses thereof |
2022-2-01 |
2022-5-13 |
|
| Gacyclidine otic formulations and uses thereof |
2021-12-22 |
2022-6-30 |
|
| Bdnf otic formulations and use thereof |
2021-12-15 |
2022-6-23 |
|
| Variant adeno-associated virus (aav)capsid polypeptides and gene therapeutics … |
2021-11-05 |
2022-5-12 |
|
| Auris formulations for treating otic diseases and conditions |
2021-8-18 |
2022-2-10 |
|
| Otic gel formulations for treating otitis externa |
2021-6-17 |
2021-12-23 |
|
| Growth factor formulation for condition associated with otic event |
2021-1-22 |
2021-7-29 |
|
| Controlled-release cns modulating compositions and methods for the treatment of … |
2021-1-12 |
2021-7-22 |
|
| Adeno-associated virus (aav) systems for treatment of genetic hearing loss |
2020-9-30 |
2021-4-08 |
|
| Growth factor otic formulations |
2020-7-01 |
2020-8-31 |
|
| Trkb or trkc agonist compositions and methods for the treatment of otic … |
2019-12-23 |
2020-6-18 |
|
| Sterilization of ciprofloxacin composition |
2019-12-04 |
2020-1-02 |
|
| Modulation of gel temperature of poloxamer-containing formulations |
2019-6-06 |
2019-10-17 |
|
| Controlled-release apoptosis modulating compositions and methods for the … |
2019-5-06 |
2019-7-31 |
|
| Otic formulations for drug-induced ototoxicity |
2019-4-25 |
2021-4-28 |
|
| Controlled release delivery devices for the treatment of otic disorders |
2019-2-27 |
2019-6-27 |
|
| Prevention of and recovery from drug-induced ototoxicity |
2019-2-27 |
2019-7-04 |
|
| Triglyceride otic formulations and uses thereof |
2018-12-21 |
2019-6-27 |
|
| Treatment using truncated Trk B and Trk C antagonists |
2018-7-20 |
2021-6-15 |
2021-6-15 |
| Auris formulations for treating otic diseases and conditions |
2018-5-23 |
2018-6-14 |
|
| Controlled release of auris sensory cell modulator compositions for the … |
2018-4-24 |
2018-9-06 |
|
| Neurotrophin mutants for treating hearing loss and other otic disorders |
2018-1-26 |
2019-12-04 |
|
| Otic gel formulations for treating otitis media |
2017-9-27 |
2018-4-05 |
|
| Controlled release antimicrobial compositions and methods for the treatment of … |
2017-9-20 |
2022-6-28 |
2022-6-28 |
| Controlled release corticosteroid compositions and methods for the treatment of … |
2017-6-02 |
2018-4-26 |
|
| Ciprofloxacin otic composition and kits and method for using same |
2016-12-09 |
2022-2-15 |
2022-2-15 |
| Methods for the treatment of pediatric otic disorders |
2016-9-13 |
2017-2-02 |
|
| Controlled release compositions for modulating free-radical induced damage and … |
2016-6-16 |
2016-10-27 |
|
| Controlled-release otic structure modulating and innate immune system … |
2016-3-23 |
2016-8-26 |
|
| Controlled release antimicrobial compositions and methods for treatment of otic … |
2016-3-11 |
2016-9-08 |
|
| Otic formulations for the treatment of ceruminosis |
2015-7-29 |
2017-8-03 |
|
| Controlled release auris sensory cell modulator compositions and methods for … |
2015-7-09 |
2015-11-05 |
|
| Controlled release aural pressure modulator compositions and methods for the … |
2014-8-21 |
2019-3-19 |
2019-3-19 |
| Controlled release antimicrobial compositions and methods for the treatment of … |
2014-1-29 |
2014-2-13 |
|
| Auris formulations for treating otic diseases and conditions |
2013-11-08 |
2014-1-16 |
|
| Controlled Release Ion Channel Modulator Compositions and Methods for the … |
2013-2-07 |
2013-6-13 |
|
| Compositions and methods for the treatment of sinonasal disorders |
2010-10-21 |
2011-9-22 |
|
| Compositions comprising wnt modulators or neurotoxins for the treatment of otic … |
2010-10-19 |
2011-9-09 |
|
| Auris formulations for treating otic diseases and conditions |
2010-10-01 |
2011-6-29 |
|
| Flow-induced delivery from a drug mass |
2010-7-19 |
2012-10-30 |
2012-10-30 |
| Treatment and/or prevention of inner ear conditions by modulation of a … |
2009-10-19 |
2010-7-08 |
|
| ANTIMICROBIAL COMPOSITIONS OF CONTROLLED LIBERATION OR DEVICES METHODS FOR THE … |
2009-7-21 |
2010-9-22 |
|
| Controlled-release otic structure modulating and innate immune system … |
2009-7-20 |
2015-9-30 |
|
| Controlled release antimicrobial compositions and methods for the treatment of … |
2009-7-20 |
2014-9-01 |
2014-9-01 |
| Controlled release cytotoxic agent compositions and methods for the treatment … |
2009-6-29 |
2009-12-31 |
|
| Formulations |
2009-6-18 |
2012-8-16 |
|
| Controlled release immunomodulator compositions and methods for the treatment … |
2009-5-26 |
2014-2-11 |
2014-2-11 |
| Controlled release corticosteroid compositions and methods for the treatment of … |
2009-5-14 |
2009-12-16 |
|
| CORTICOESTEROID COMPOSITIONS OF CONTROLLED RELEASE AND METHODS FOR THE … |
2009-5-14 |
2010-8-18 |
|
| Anti-apoptotic composition and methods for the treatment of otic disorders |
2009-4-24 |
2009-6-03 |
|
| Slow release NMDA receptor antagonist for otic disorders |
2009-4-24 |
2011-2-16 |
2011-2-16 |
| FORMULATIONS FOR THE EAR TO TREAT OPTICAL DISEASES AND CONDITIONS |
2009-4-21 |
2009-12-14 |
|
| Controlled Release Corticosteroid Compositions and Methods for the Treatment of … |
2008-12-22 |
2010-3-31 |
2010-3-31 |
| Apparatus and method for delivery of therapeutic and other types of agents |
2006-5-01 |
2007-11-01 |
|
| Improved gacyclidine formulations |
2006-3-06 |
2011-12-14 |
|